Bristol-Myers Squibb Co. (NYSE:BMY)

Major Pharma Sees Fading Short Interest

Posted: January 11, 2019 at 9:50 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Thursday’s Biggest Winners and Losers in the S&P 500

Posted: January 3, 2019 at 4:08 pm

January 3, 2019: The S&P 500 closed down 2.5% at 2,447.96. The DJIA closed down 2.8% at 22,686.36. Separately, the Nasdaq closed down 3.0% at 6,463.50. Thursday was a down ...
Read Full Story »

Apple, Bristol-Myers Plummet into Thursday’s 52-Week Low Club

Posted: January 3, 2019 at 4:02 pm

January 3, 2019: Here are four stocks trading with heavy volume among 66 equities trading at new 52-week lows shortly before Thursday's closing bell. On the NYSE, decliners led advancers ...
Read Full Story »

Bristol-Myers, Celgene to Tie a $74 Billion Knot

Posted: January 3, 2019 at 8:50 am

There's nothing like spending $74 billion on an acquisition to get shareholders' attention. That's what Bristol-Myers Squibb Co. (NYSE: BMY) found out Thursday morning following the announcement of a definitive ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma Stocks

Posted: December 27, 2018 at 10:00 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Stocks See a Surge in Short Interest

Posted: December 12, 2018 at 9:50 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Health Care Catalysts Coming by the End of 2018

Posted: December 8, 2018 at 7:20 am

Companies in the health care sector face great risk and great reward every time they make an announcement. Drug candidates passing clinical trials, gaining regulatory approval or being canceled can ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alphabet, American Water, Apple, Facebook, Macy’s, Southern Copper, Twitter, YY and Many More

Posted: December 6, 2018 at 9:10 am

Stocks were set to open lower on Thursday after Wednesday's market closures. The drop is on the heels of what already felt like a buyer's strike of a major sell-off ...
Read Full Story »

Short Sellers Hike Their Bets in Major Pharma Stocks

Posted: November 28, 2018 at 9:00 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Bristol-Myers Loses Out in Late-Stage Lung Cancer Study

Posted: November 27, 2018 at 12:00 pm

Bristol-Myers Squibb Co. (NYSE: BMY) shares dipped on Tuesday after the company reported results from its late-stage lung cancer study. The firm announced that its Phase 3 CheckMate 451 study ...
Read Full Story »

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

Posted: November 12, 2018 at 10:10 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Short Sellers Hike Their Bets

Posted: October 25, 2018 at 9:00 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Biotech Earnings Reports to Watch This Week

Posted: October 21, 2018 at 10:15 am

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week. While ...
Read Full Story »

How Compugen Is Weathering Thursday’s Storm

Posted: October 11, 2018 at 1:20 pm

Compugen Ltd. (NASDAQ: CGEN) shares pushed higher on Thursday after it was announced that Bristol-Myers Squibb Co. (NYSE: BMY) will make a $12 million equity investment as part of its ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma

Posted: October 10, 2018 at 9:10 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »